Biostar Pharma Revenue, Profits - BSPM Annual Income Statement

Add to My Stocks
$1.88 $0.06 (3.3%) BSPM stock closing price Sep 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Biostar Pharma stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the BSPM stock is bound to reflect the impact of the YOY decline of -91.22%. The operating expenses as shown in the Biostar Pharma profit and loss statement for 2016 total to $4.47M. This line item shows that the operating expenses has decreased compared with last year. Also check: Biostar Pharma assets and Biostar Pharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201620152014201320122011201020092008
Biostar Pharma Revenues or Net Sales
2.38M27.12M61.41M52.72M49.31M91.96M80.21M53.31M33.91M
Cost Of Goods Sold (COGS)1.46M16.02M31.14M27.04M19.46M27.57M20.07M14.31M14.05M
Biostar Pharma Gross Profit
-11.1M30.27M25.68M29.85M64.38M60.13M39M19.85M
Research & Development Expense1.14M4.02M2.76M3.22M4.47M2.32M---
Selling General & Admin Expense3.33M30.84M28.82M21.94M47.16M43.9M36.52M23.9M12.09M
Income Before Depreciation Depletion Amortization-3.56M-23.75M-1.31M--21.78M18.15M23.61M15.1M7.76M
Depreciation Depletion Amortization---------
Non Operating Income--3M2.51M--0.05M-0.15M-0.35M-
Interest Expense---------
Biostar Pharma Pretax Income
-3.04M-23.79M1.53M2.65M-21.57M18.06M23.45M14.74M7.72M
Provision for Income Taxes2.65M1.31M-3.31M1.84M-1.57M5.89M6.07M4.25M1.03M
MinorityInterest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-5.69M-25.11M4.84M--19.99M12.17M17.38M10.49M6.69M
Extraordinary Items & Discontinued Operations---------
Biostar Pharma Profit/ Loss (Net Income)
-5.69M-25.11M4.84M--19.99M12.17M17.38M10.49M6.69M
Average Shares used to compute Diluted EPS2.3M2.21M2.07M1.93M1.37M1.33M1.31M1.16M1.11M
Average Shares used to compute Basic EPS2.3M2.21M2.07M1.93M1.37M1.33M1.26M1.11M1.07M
Income Before Nonrecurring Items-5.7M-25.11M4.88M--13.33M13.96M17.38M10.5M6.69M
Income from Nonrecurring Items---0.03M-0.16M-6.67M-1.78M---
Biostar Pharma Earnings Per Share Basic Net
-2.48-11.362.310.42-14.639.2413.867.144.83
Biostar Pharma Earnings Per Share Diluted Net
-2.48-11.362.310.42-14.639.2413.236.724.62
EPS Diluted Before Nonrecurring Items-2.48-11.362.310.49-9.7310.5013.236.724.62
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Biostar Pharma stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Biostar Pharma revenue chart, as isn't the case with Biostar Pharma indicates a sagging business. One needs to compare the YoY topline or sales growth of BSPM stock with its peers like APRI stock and RXII stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. BSPM stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The BSPM financials along with Biostar Pharma historical stock prices provide a lot of details about the firm.

Biostar Pharma Income Statement - Key Financial Ratios